Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous NK Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00815321
What this trial is testing

Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy

Who this might be right for
Chronic Myeloid Leukemia
Singapore General Hospital 11
Not applicableStudy completedNCT00569309
What this trial is testing

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell NeoplasmSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT07271446
What this trial is testing

An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Precision Biotech Taiwan Corp. 8
Not applicableLooking for participantsNCT05676190
What this trial is testing

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

Who this might be right for
Colorectal Cancer
ShiCang Yu 80
Early research (Phase 1)Study completedNCT02955550
What this trial is testing

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Celularity Incorporated 15
Early research (Phase 1)Study completedNCT01875601
What this trial is testing

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Who this might be right for
Solid TumorsBrain TumorsSarcoma+2 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT03894579
What this trial is testing

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
NKGen Biotech, Inc. 9
Early research (Phase 1)Ended earlyNCT01678443
What this trial is testing

Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+30 more
Fred Hutchinson Cancer Center 2
Early research (Phase 1)UnknownNCT03542669
What this trial is testing

Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer

Who this might be right for
Recurrent Ovarian CarcinomaPlatinum-resistant Ovarian Cancer
Peking University People's Hospital 9
Not applicableWithdrawnNCT05869994
What this trial is testing

Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

Who this might be right for
Sarcoma
Sarcoma Oncology Research Center, LLC
Very early researchLooking for participantsNCT07162012
What this trial is testing

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

Who this might be right for
NK/T-cell LymphomaPeripheral T-cell Lymphoma (PTCL)DLBCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Testing effectiveness (Phase 2)WithdrawnNCT03579927
What this trial is testing

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

Who this might be right for
CD19 PositiveMantle Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma+4 more
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT06044506
What this trial is testing

Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Dr Cipto Mangunkusumo General Hospital 3
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Very early researchNot Yet RecruitingNCT07709299
What this trial is testing

Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)
Royan Institute 6
Testing effectiveness (Phase 2)Study completedNCT01007526
What this trial is testing

Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma

Who this might be right for
NK/T-cell Lymphoma of Nasal Cavity
Samsung Medical Center 31
Not applicableStudy completedNCT07692607
What this trial is testing

Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
LucasBio 25
Early research (Phase 1)UnknownNCT04309084
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasm, Plasma CellNeoplasms by Histologic Type+17 more
Celularity Incorporated 29
Testing effectiveness (Phase 2)UnknownNCT05461235
What this trial is testing

Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma

Who this might be right for
PD-1 AntibodyDC-CellNK-Cell+1 more
China Medical University, China 1
Early research (Phase 1)Study completedNCT00720785
What this trial is testing

Natural Killer Cells and Bortezomib to Treat Cancer

Who this might be right for
Chronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Next Page